Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The prescription peptides semaglutide, liraglutide, and tirzepatide are generally intended for people with a body mass index (BMI) of 30 or higher , or a BMI of 27 or higher with weight-related health conditions such as type 2 diabetes, high blood pressure, or sleep apnea (FDA Wegovy prescribing information)
The active ingredient in this pen is FDA-approved Semaglutide base 0.25 mg/0.5 mg, a Glucagon-like Peptide-1 (GLP-1) receptor agonist
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for managing type 2 diabetes mellitus, though some are now also licensed for weight management in adults with obesity
Repeated vomiting can cause severe dehydration, damage to the esophagus, and acidic erosion of the tooth enamel
US$ 28.87
US$ 24.50
US$ 23.14
